Nearly four years ago, Syngenta Seeds committed to investing $400 million in research and development by 2022. Syngenta Seeds Strategic Marketing Manager Drew Showalter says the results from that investment are now evident. “The breeders that were brought into Brookings (South Dakota) are now in year three or four of their program. The fruits of the investment are really coming to fruition in the north.” Syngenta’s Enogen corn enzyme technology began 11 years ago with a focus on the ethanol business. That has expanded to cattle rations. “The alpha amylase simply breaks down starches so it is easier to access that starch in an ethanol plant. It’s the same story for the belly of a cow or a steer.” Showalter previously served as the sales manager for Golden Harvest in North Dakota, northern Minnesota and northern Wisconsin.
Subscribe to RRFN
Get a weekly digest from RRFN to stay up-to-date on all the latest news in agriculture.